Table 2 Adverse effects associated with amikacin
| Adverse effects | N (%) |
|---|---|
| Ototoxicity | |
| Subjective symptoms | 43/107 (40.2%) |
| Hearing impairment seen in audiograms | 30/77 (39.0%) |
| Nephrotoxicity | 6/96 (6.2%) |
| Vestibular toxicity | 4/107 (3.7%) |
| PICC related complications | |
| Venous thromboembolism | 7/107 (6.5%) |
| Bloodstream infection | 1/107 (0.9%) |
| Fatigue | 6/107 (5.6%) |
| Skin rash | 5/107 (4.7%) |
| Paresthesias | 1/107 (0.9%) |
| Restless extremities | 1/107 (0.9%) |